Fundraising Fox

re.Mind Capital

Venture capitaloperating company · company profile

London · Pre-Seed–Series A · 3 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

An early-stage venture capital firm focused exclusively on investing in mental health, brain health, and human flourishing companies.

Source: firm website, verified Aug 6, 2026.

Stage
Pre-Seed–Series A
HQ
London, GB
Instruments
Equity
Tracked investments
1

Team · 3 people

from public directories
Max de Vere· Investorin

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Deep Tech ×1Medical Devices ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Synchronsynchron.comin𝕏May 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Director)

BoardRahul Sharma(Director)Alex Morgan(Director)inMartin Dieck(Director)

Co-investorsARCH Venture PartnersForepont Capital PartnersID8 InvestmentsKaleida CapitalKhosla VenturesBezos Expeditions+4 more

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does re.Mind Capital invest at?
re.Mind Capital invests at the Pre-Seed, Seed, Series A stages.
What sectors does re.Mind Capital focus on?
re.Mind Capital focuses on Healthtech, Mental Health, Wellness & Fitness.
Where is re.Mind Capital located?
re.Mind Capital is headquartered in London, GB.

Co-investors · 3

Founders Fund

Founders Fund is a venture capital firm that backs technology companies building transformative products.

$500K – $5M
What If Ventures

What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.

Mystic Ventures

Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.

Firms observed investing alongside re.Mind Capital, from public investor directories. Shared companies are the overlap with re.Mind Capital's recorded portfolio.

Similar investors

Featured in lists